Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04926831 |
| Title | Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N) |
| Acronym | Geometry-N |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Oncology Hematology . | La Jolla | California | 92037 | United States | Details | |
| University of California Davis Cancer Center . | Sacramento | California | 95817 | United States | Details | |
| Fairfax-Northern Virginia Hematology-Oncology . | Fairfax | Virginia | 22031 | United States | Details |